AmnioLife Corporation

BiotechnologySeries AGainesville, USamniolife.com

Latest round

Series A

Last raised

Jan 2016

Total raised

$1.5M

Investors

2

About AmnioLife Corporation

AmnioLife Corporation is based in Gainesville, US and was founded in 2013. The firm operates as a developer of biologic suite of products designed to address underserved and unmet market needs with product applications across various collagen repair markets.

Who invested in AmnioLife Corporation

2 investors across 2 rounds

See all investors in AmnioLife Corporation

Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.

Funding rounds

  1. Series A

    Jan 6, 2016

    Amount

    $0.7M

    Investors

    Locked

  2. Series A

    Jun 5, 2015

    Amount

    $0.8M

    Investors

    Locked

Questions about AmnioLife Corporation

Who invested in AmnioLife Corporation?

AmnioLife Corporation has 2 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.

How much funding has AmnioLife Corporation raised?

AmnioLife Corporation has raised 2 venture rounds. Sign up free to see how much each round raised and the total.

When did AmnioLife Corporation last raise money?

AmnioLife Corporation's most recent round on record is a Series A, in Jan 2016.

What does AmnioLife Corporation do?

AmnioLife Corporation is based in Gainesville, US and was founded in 2013.

Where is AmnioLife Corporation headquartered?

AmnioLife Corporation is headquartered in Gainesville, US.

Which VCs invest in companies like AmnioLife Corporation?

Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at AmnioLife Corporation's stage. Their profiles are linked below.

Raising like AmnioLife Corporation? Find the right VCs.

Capital Atlas matches your startup to active investors by stage, sector and region.

Free to start. Upgrade when you're ready to reach out.